Investing Profile

Sakae Asanuma

InvestorVC
President & CEO at Taiho Ventures
taihoventures.com/team.htmlSan Francisco, California
Photo of Sakae Asanuma, President at Taiho Ventures
Your Intro Paths to Sakae Asanuma
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Sakae Asanuma on

cb
Current Investing Position
Taiho Ventures President
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
11
Current Fund Size
$150M

Sakae Asanuma is on these Sector & Stage Rankings

Sakae Asanuma's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Anavo Therapeutics
SeedMay 2023$9M
SeedApr 2021$24M
$33M
Co-investors: Therese Liechtenstein (M Ventures (Merck)), Debora Dumont (Bioqube Ventures), Simone Botti (INKEF Capital)
Cellvie
SeedFeb 2023$6M
$6M
Dren Bio
Series BJun 2022$65M
Series AOct 2020$60M
$130M
Co-investors: Andrew Schiff (Aisling Capital), Rajeev Dadoo (SR One), Chandra Leo (Hbm Partners)
Axial Biotherapeutics
Series COct 2021$37M
Series BJun 2019$10M
$86M
Co-investors: Nora Frey (Seventure Partners), Rich Aldrich (Longwood Fund), James Blair (Domain Associates)
Orna Therapeutics
Series AFeb 2021$80M
$320M
Co-investors: Ansbert Gadicke (MPM Capital), Shinichiro Fuse
Theolytics
Series AJan 2021$7M
$7M
Co-investors: Therese Liechtenstein (M Ventures (Merck))
Storm Therapeutics
Series AMay 2019$18M
Series AJan 2018$5M
$69M
Co-investors: Bruno Montanari (Seroba Life Sciences), Hakan Goker (M Ventures (Merck))